Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma 32Lymphoma, Follicular 26Myelodysplastic Syndromes 24Lymphoma, Large B-Cell, Diffuse 24Lymphoma, Non-Hodgkin 23Leukemia, Myeloid, Chronic-Phase 23Burkitt Lymphoma 22Leukemia, Myeloid, Accelerated Phase 21Leukemia, Myeloid, Acute 20Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Lymphocytic, Chronic, B-Cell 19Lymphoma, Mantle-Cell 16Lymphoma, B-Cell, Marginal Zone 16Graft vs Host Disease 16Multiple Myeloma 15Dendritic Cell Sarcoma, Interdigitating 15Blast Crisis 15Myeloproliferative Disorders 14Leukemia, Myelomonocytic, Chronic 14Hodgkin Disease 14Anemia, Refractory, with Excess of Blasts 13Recurrence 11Neoplasms, Plasma Cell 11Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 11Congenital Abnormalities 11Myelodysplastic-Myeloproliferative Diseases 10Leukemia, Biphenotypic, Acute 10Sezary Syndrome 8

Interventions

tocilizumab 1fish oil triglycerides 1Methylprednisolone 1Diagnosis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colitis × Methylprednisolone × Clear all
NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Prometheus Laboratories

Phase 2 Completed
190 enrolled
Lymphoid

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡